chr10-131166826-T-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_174937.4(TCERG1L):āc.916A>Cā(p.Lys306Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000294 in 1,613,790 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_174937.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000177 AC: 27AN: 152236Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000207 AC: 52AN: 250916Hom.: 0 AF XY: 0.000192 AC XY: 26AN XY: 135650
GnomAD4 exome AF: 0.000307 AC: 448AN: 1461554Hom.: 0 Cov.: 31 AF XY: 0.000304 AC XY: 221AN XY: 727068
GnomAD4 genome AF: 0.000177 AC: 27AN: 152236Hom.: 0 Cov.: 33 AF XY: 0.000134 AC XY: 10AN XY: 74368
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 06, 2022 | The c.916A>C (p.K306Q) alteration is located in exon 5 (coding exon 5) of the TCERG1L gene. This alteration results from a A to C substitution at nucleotide position 916, causing the lysine (K) at amino acid position 306 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at